Oncolytics Biotech (ONCY)
(Delayed Data from NSDQ)
$0.92 USD
-0.03 (-2.75%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.92 0.00 (-0.42%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/01/2024
Time: -- |
9/2024 | $-0.08 | 0.00% |
Earnings Summary
For their last quarter, Oncolytics Biotech (ONCY) reported earnings of -$0.07 per share, beating the Zacks Consensus Estimate of $-0.08 per share. This reflects a positive earnings surprise of 12.50%. Look out for ONCY's next earnings release expected on November 01, 2024. For the next earning release, we expect the company to report earnings of -$0.08 per share, reflecting a year-over-year increase of 20%.
Earnings History
Price & Consensus
Zacks News for ONCY
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
ONCY: What are Zacks experts saying now?
Zacks Private Portfolio Services